Cargando…
EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
LMP1, which is encoded by the Epstein-Barr virus, is proposed to be one of the major oncogenic factors involved in nasopharyngeal carcinoma (NPC). Previous studies demonstrated that down-regulation of LMP1 by LMP1-targeted DNAzyme (DZ1) increases the radiosensitivity of NPC. However, the mechanism b...
Autores principales: | Yang, Lifang, Liu, Liyu, Xu, Zhijie, Liao, Weihua, Feng, Deyun, Dong, Xin, Xu, San, Xiao, Lanbo, Lu, Jingchen, Luo, Xiangjian, Tang, Min, Bode, Ann M., Dong, Zigang, Sun, Lunquan, Cao, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467403/ https://www.ncbi.nlm.nih.gov/pubmed/25714020 |
Ejemplares similares
-
Correction: Yang L, et al., “Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity”, Cancer Biol Ther 2014; 15:61–8
por: Yang, Lifang, et al.
Publicado: (2014) -
A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
por: Yang, Lifang, et al.
Publicado: (2010) -
Down-Regulation of EBV-LMP1 Radio-Sensitizes Nasal Pharyngeal Carcinoma Cells via NF-κB Regulated ATM Expression
por: Ma, Xiaoqian, et al.
Publicado: (2011) -
(−)-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes
por: Li, Hongde, et al.
Publicado: (2021) -
Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model
por: Chen, Yan, et al.
Publicado: (2013)